| |
Federal Government NIAID Aging Funding Opportunities
|
| |
| |
From 2000 to 2004, CDC reports that the proportion of AIDS patients 50+ years old rose from 19% to 27% and the number of older adults 50+ years living with HIV infection and/or AIDS more than doubled. Importantly, for that surveillance period, persons ages 40-49 years had the highest prevalence of HIV/AIDS and the steepest rise in prevalence. Thus the number of older people with HIV/AIDS is expected to increase even further during the next decade as this "younger" group survives with current treatment and moves into the "older" age group. It is projected that, by 2015, more than half of all HIV-infected individuals in the U.S. will be over the age of 50.
Younger adults aging with HIV on prolonged treatment with HAART frequently experience long-term side effects of disease and treatment that mimic or accelerate aging processes (e.g., age-related changes in immune function, early bone mineral loss, and accelerated age-associated conditions such as atherosclerosis).
PA-09-019,
Medical Management of Older Patients with HIV/AIDS
DAIDS R21 Elec.
Standard AIDS submission dates through
2012-01-08.
PA-09-018, Medical Management of Older Patients with HIV/AIDS
DAIDS R03 Elec. Standard AIDS submission dates through
2012-01-08.
PA-09-017, Medical Management of Older Patients with HIV/AIDS
DAIDS R01 Elec. Standard AIDS submission dates through
2012-01-08.
|
|
| |
| |
|
|
|
